• Home
  • About Us

Idiopathic Pulmonary Fibrosis

Jeremy Feldman, MD

  • What is Idiopathic Pulmonary Fibrosis?
    • Idiopathic Pulmonary Fibrosis Definition
    • Symptoms of Idiopathic Pulmonary Fibrosis
    • Causes of Idiopathic Pulmonary Fibrosis
    • Who Gets Idiopathic Pulmonary Fibrosis
    • Gastro-Esophageal Reflux (GER) and Idiopathic Pulmonary Fibrosis
    • Interstitial Lung Disease vs. Idiopathic Pulmonary Fibrosis
    • Is Pulmonary Fibrosis Hereditary?
    • Research, Life Expectancy and Prognosis for Idiopathic Pulmonary Fibrosis
  • Diagnosing & Monitoring PF
    • Monitoring Progress of IPF
    • Idiopathic Pulmonary Fibrosis Diagnosis
    • Chest X-rays Used in IPF
    • CPET used in IPF
    • HRCT Scans Used to Evaluate IPF
    • Lung Biopsy To Diagnose IPF
    • Pulmonary Function Tests (PFTS)
    • Six Minute Walk Test To Monitor IPF
    • Stages of Idiopathic Pulmonary Fibrosis
    • Complications of Idiopathic Pulmonary Fibrosis
  • PF Treatment Options
    • Esbriet (pirfenidone) Used to Treat IPF
    • OFEV (nintedanib) Used to Treat IPF
    • Pulmonary Rehab for IPF Patients
    • Lung Transplantation for Pulmonary Fibrosis
    • Oxygen Used to Treat IPF
      • Update on Oxygen Use
    • Clinical Trials in Idiopathic Pulmonary Fibrosis
    • IPF & Leg Swelling
    • Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis
    • IPF Exacerbation
  • PF Advocacy & News
  • FAQ’s
    • Respiratory failure, NSIP, diet
    • Leg swelling, lung biopsy, side effects & pets
    • FAQ’s Enzyme Therapy, Progression of IPF & Oxygen
    • FAQ: Diarrhea, Fibrosis Reversal, IPF Symptoms
    • FAQ: Oxygen Flow, Anesthesia & Genetics
    • FAQ: Contagious Cough? Stem Cells, Familial IPF, Flying
    • FAQ: GERD, Fatigue & Environmental Exposure
    • FAQ: How to Travel to Your Doctor’s Office with Oxygen
    • FAQ: Lung Biopsy with Pulmonary Fibrosis
    • FAQ’s: Alcohol, Clinical Trials, Pulmonary Function Testing
    • FAQs: Emphysema, Exercise & Lung Biopsy

Pulmonary Rehab for IPF Patients

What is Pulmonary Rehabilitation?

Pulmonary Rehab for IPF patientsPulmonary rehab is a structured exercise program for patients with lung disease. The focus is on improving exercise capacity, muscle strength and education about proper breathing techniques and oxygen usage. These programs usually take place in the outpatient part of a hospital’s therapy department. Most programs meet two to three times a week for a couple of hours. Patients perform a variety of aerobic exercises and weight training. Patients are monitored by exercise physiologists and respiratory therapists.

Why exercise?

As idiopathic pulmonary fibrosis progresses over time, patients gradually reduce their activity level. This results in a slow deconditioning process that makes activity progressively harder. This feed-forward cycle eventually results in loss of muscle strength in the legs and arms. This reduction in muscle strength then further amplifies exercise limitation.

Can anything be done to break the cycle? Exercise can help. In studies that compare a group of patients that participated in structured exercise to a Exercise with IPFgroup that did not, the exercising group had significant improvements in the distance they can walk in six minutes. In some studies patients also reported quality of life improvements.

Other benefits of exercise include confidence building and providing patients with a sense of community. Patients that require oxygen often are self-conscious and as a result tend to isolate themselves. Being in an environment where everyone is in the same boat can be very reassuring. Meeting other patients also can provide an important sense of community. Much like a support group, the comradery that develops provides further benefit.

Pulmonary Rehab and Lung Transplantation

All patients being considered for lung transplantation need to participate in pulmonary rehab. In order to optimize a patient’s post-transplant recovery they need to have enough muscle strength to participate in physical therapy. Pre-transplant pulmonary rehab begins the process of post-transplant reconditioning. Patients also benefit from seeing other patients on the waiting list for lung transplantation as well as patients who have already received their transplantation.

Featured Blog Posts

Esbriet approved by FDA

How Will I Afford My IPF Medication?

Research for IPF

4 Vaccinations for Pulmonary Fibrosis Patients

Pulmonary Fibrosis Medical Professionals

How to Get the Most Out of Your Doctor’s Visit

Recent Posts

  • Interstitial Lung Disease and Progressive Pulmonary Fibrosis
  • Pamrevlumab Ineffective in Treating IPF
  • New Drugs Moving Forward for IPF

Search by Keyword (Examples: GERD, Coughing, Traveling, etc.)

Search by Category

Popular Articles

IPF patient with doctor

Idiopathic Pulmonary Fibrosis Treatment Options

What is IPF?

  • What is Idiopathic Pulmonary Fibrosis?
    • Symptoms of Idiopathic Pulmonary Fibrosis
    • Causes of Idiopathic Pulmonary Fibrosis
    • Who Gets Idiopathic Pulmonary Fibrosis
    • Gastro-Esophageal Reflux (GER) and IPF
    • Interstitial Lung Disease vs. Idiopathic Pulmonary Fibrosis
    • Is Pulmonary Fibrosis Hereditary?
    • Research, Life Expectancy & Prognosis for Pulmonary Fibrosis

Diagnosing IPF

  • Idiopathic Pulmonary Fibrosis Diagnosis
    • Chest X-rays Used in IPF
    • CPET used in IPF
    • HRCT Scans Used to Evaluate IPF
    • Lung Biopsy To Diagnose IPF
    • Pulmonary Function Tests (PFTS)
    • Six Minute Walk Test To Monitor IPF
    • Stages of Idiopathic Pulmonary Fibrosis
    • Complications of Idiopathic Pulmonary Fibrosis

Treating IPF

  • Pulmonary Fibrosis Treatment Options
    • Esbriet (pirfenidone) Used to Treat IPF
    • OFEV (nintedanib) Used to Treat IPF
    • Pulmonary Rehab for IPF Patients
    • Lung Transplantation for Pulmonary Fibrosis
    • Oxygen Used to Treat IPF
    • Clinical Trials in Idiopathic Pulmonary Fibrosis
    • IPF & Leg Swelling
    • Pulmonary Hypertension and Idiopathic Pulmonary Fibrosis
    • IPF Exacerbation

Disclaimer